This review provides an overview of the scope, presentation, and management of group B streptococcal perinatal infections. Recently described information, including changes in the epidemiology, the emergence of serotype V, and the decline in early-onset infections after implementation of guidelines for maternal intrapartum chemoprophylaxis, is emphasized.
